Unihealth Consultancy Ltd Financials
Company Logo

Unihealth Consultancy Ltd Financial Statement

Unihealth Consultancy Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Unihealth Consultancy Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual4.23
Operating Expenses Annual2.28
Operating Profit Annual4.28
Interest Annual0.34
Depreciation0.16
Net Profit Annual3.04
Tax Annual0.75

Unihealth Consultancy Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.04
Cash Flow from Operations-2.46
Cash Flow from Investing-10.50
Cash Flow from Financing39.57
Cash Flow at the End26.64

Unihealth Consultancy Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)101.18
PBIT Margin (%)97.40
PBT Margin (%)-189.83
Net PROFIT Margin (%)71.87
Return On Networth / Equity (%)7.67
Return On Networth /Employed (%)8.69
Return On Assets (%)6.47
Total Debt / Equity (X)0.20
Asset Turnover Ratio (%)0.09

Unihealth Consultancy Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual3.09
Total Current Assets Annual31.28
Non Current Assets Annual37.20
Total Shareholders Funds Annual64.47
Total Assets Annual68.48

Unihealth Consultancy Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 20, 2024, Unihealth Consultancy Ltd has a market capitalization of 207.90 Cr. Value Research classifies it as a Small-Cap company.
Yes, Unihealth Consultancy Ltd is debt-free with a debt-to-equity ratio of 0.05.
In FY 2023 , Unihealth Consultancy Ltd recorded a total revenue of approximately 4.23 Cr marking a significant milestone in the company's financial performance.
Unihealth Consultancy Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.5% annually, respectively..
Unihealth Consultancy Ltd's current PE ratio is 68.39.
Unihealth Consultancy Ltd's ROCE averaged 8.1% from the FY ending March 2022 to 2024, with a median of 9.2%. It peaked at 9.2% in March 2022, reflecting strong capital efficiency over the period..
Unihealth Consultancy Ltd's latest EBIT is Rs. 4.13 Cr, surpassing the average EBIT of Rs. 2.69 Cr over the 5 years..